ArticleRheumatology and therapy2024

A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers.

Lyrialle W Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.